The landscape of blood sugar treatment is evolving with the emergence of transdermal GLP-1 delivery . These convenient delivery systems offer a potentially less invasive alternative to injections for individuals living with type 2 diabetes . Such a system deliver a GLP-1 agonist directly through the epidermis, circumventing the necessity for reg… Read More